EFL006
Join host Dr. Chase Hendrickson, Vanderbilt University Medical Center, Dr. Steve Wittlin, Professor of Medicine at the University of Rochester School of Medicine and Dentistry and Director of Diabetes Services/Endocrine-Metabolism Division at the University of Rochester Medical Center, and Dr. Anne Peters, Professor of Clinical Medicine at the Keck School of Medicine, University of Southern California, and Director of the USC Clinical Diabetes Program, as they discuss an upcoming JCEM article, “Artificial Pancreas with Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes.”
Meet the Speakers
Anne L. Peters, MD, is a professor of clinical medicine at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs diabetes centers in Beverly Hills and in underserved East Los Angeles. In addition to her clinical work, she has been a PI on multiple grants and has written over 200 articles and 4 books. She has been on multiple guideline writing committees for both type 1 and type 2 diabetes. Her major interests involve translating research findings, from lifestyle interventions to technology, to people with diabetes throughout the socioeconomic spectrum. She lives between Los Angeles and Montana.
Steven Wittlin, MD, received his medical degree from Sackler School of Medicine, Tel Aviv University and completed his residency, including serving as chief resident, at Booth Memorial Medical Center in New York. Dr. Wittlin completed his fellowship at New York University. Dr. Wittlin is a past Chief of Endocrinology and Assistant Chairman of Medicine at Booth Memorial Medical Center for over 25 years. Currently, Dr. Wittlin is a Professor of Medicine at the University of Rochester School of Medicine and Dentistry, where he also serves as the Director of Diabetes Services and Clinical Director of the Endocrine-Metabolism Division at the University of Rochester Medical Center. Dr. Wittlin's research interests include diabetes, diabetes technology, and innovative treatments for diabetes. Dr. Wittlin has published numerous peer-reviewed articles and book chapters, and received several teaching awards.
Resources